Thomas Hohlfeld
Duesseldorf, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 50 publications
Free Fatty Acids Link Residual Lipid and Thrombotic Risk via Impairment of Aspirin Antiplatelet Effects.
Journal: Thrombosis and haemostasis
Published: December 04, 2025
Icosapent ethyl reduces arterial thrombosis by inhibition of cyclooxygenase-1-induced platelet reactivity.
Journal: Science translational medicine
Published: May 21, 2025
Acetylsalicylic acid improves outcome after acute myocardial infarction by reducing thromboinflammation.
Journal: Journal of thrombosis and haemostasis : JTH
Published: March 15, 2025
Left ventricular-aortic angle is associated with platelet reactivity in patients with aortic stenosis.
Journal: Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis
Published: July 22, 2022
Staphylococcus aureus increases platelet reactivity in patients with infective endocarditis.
Journal: Scientific reports
Published: March 30, 2022
High On-Treatment Platelet Reactivity: Aspirin versus Clopidogrel.
Journal: Pharmacology
Published: March 27, 2022
Excess Mortality in Aspirin and Dipyrone (Metamizole) Co-Medicated in Patients With Cardiovascular Disease: A Nationwide Study.
Journal: Journal of the American Heart Association
Published: November 02, 2021
Impact of Transcatheter Aortic Valve Implantation on Thrombin Generation and Platelet Function.
Journal: Thrombosis and haemostasis
Published: March 24, 2021
Noncanonical Effects of Oral Thrombin and Factor Xa Inhibitors in Platelet Activation and Arterial Thrombosis.
Journal: Thrombosis and haemostasis
Published: September 17, 2020
Response by Petzold et al to Letter Regarding Article, "Rivaroxaban Reduces Arterial Thrombosis by Inhibition of Fxa-Driven Platelet Activation via Protease Activated Receptor-1".
Journal: Circulation research
Published: May 08, 2020
Response by Petzold et al to Letter Regarding Article, "Rivaroxaban Reduces Arterial Thrombosis by Inhibition of FXa-Driven Platelet Activation via Protease Activated Receptor-1".
Journal: Circulation research
Published: April 10, 2020
Lipid lowering therapy in cardiovascular disease: From myth to molecular reality.
Journal: Pharmacology & therapeutics
Published: February 03, 2020
Last Updated: 09/26/2026